1H,1H,2H,2H-Perfluorooctyltriethoxysilane, 97%, 500g

Tideglusib, 98.0%, 5g

(S)-[4-(Pyridin-4-yl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine-2,6-diyl]bis[bis[4-(tert-butyl)phenyl]methanol]>85.0%(HPLC)50mg

5-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole, 95.0%, 500g

5,5'-(Ethane-1,2-diyl)diisophthalic acid, 98%, 100mg

Ethyl 5-bromoisoxazole-3-carboxylate, 97.0%, 1g

7-Bromoisochroman, 95.0%, 25g

1H-Pyrrolo[3,2-b]pyridine-5-carboxylic acid, 95.0%, 250mg

3-Oxo-3-thiophen-2-yl-propionic acid ethyl ester, 97.0%, 5g

tert-Butyl N-[1-(4-bromophenyl)cyclopropyl]carbamate, 95.0%, 250mg

3-Chlorobenzophenone, 95.0%, 500g

Flacon à col étroit carré en verre transparent, 1000 ml, 45, forme haute, 10 pièce(s)

6-CHLORO-3,3-DIMETHYL-2,3-DIHYDRO-1H-PYRROLO[3,2-B]PYRIDINE, 95.0%, 250mg